As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck another deal to purchase Surf Bio. To take over Surf, Halozyme is paying $300 ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zag Bio™, Inc., a biotechnology company pioneering thymus-targeted medicines, today announced the appointment of Jan Hillson, M.D., a physician-scientist and ...

Zag Bio™, Inc., a biotechnology company pioneering thymus-targeted medicines, today announced the appointment of Jan Hillson, M.D., a physician-scientist and rheumatologist with over 20 years of ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully ...

Sanofi SNY announced that the FDA has accepted a regulatory filing seeking to expand the use of its type 1 diabetes (T1D) drug, Tzield (teplizumab), in individuals aged one year and older. The agency ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generation Bio, which once ...

We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...